These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

820 related items for PubMed ID: 15353553

  • 1. MyD88 but not TRIF is essential for osteoclastogenesis induced by lipopolysaccharide, diacyl lipopeptide, and IL-1alpha.
    Sato N, Takahashi N, Suda K, Nakamura M, Yamaki M, Ninomiya T, Kobayashi Y, Takada H, Shibata K, Yamamoto M, Takeda K, Akira S, Noguchi T, Udagawa N.
    J Exp Med; 2004 Sep 06; 200(5):601-11. PubMed ID: 15353553
    [Abstract] [Full Text] [Related]

  • 2. Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.
    Yang S, Takahashi N, Yamashita T, Sato N, Takahashi M, Mogi M, Uematsu T, Kobayashi Y, Nakamichi Y, Takeda K, Akira S, Takada H, Udagawa N, Furusawa K.
    J Immunol; 2005 Aug 01; 175(3):1956-64. PubMed ID: 16034140
    [Abstract] [Full Text] [Related]

  • 3. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
    Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, Akira S.
    Science; 2003 Aug 01; 301(5633):640-3. PubMed ID: 12855817
    [Abstract] [Full Text] [Related]

  • 4. Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation.
    Suda K, Udagawa N, Sato N, Takami M, Itoh K, Woo JT, Takahashi N, Nagai K.
    J Immunol; 2004 Feb 15; 172(4):2504-10. PubMed ID: 14764723
    [Abstract] [Full Text] [Related]

  • 5. Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha.
    Hayashi S, Yamada T, Tsuneto M, Yamane T, Takahashi M, Shultz LD, Yamazaki H.
    J Immunol; 2003 Nov 15; 171(10):5130-9. PubMed ID: 14607912
    [Abstract] [Full Text] [Related]

  • 6. 1,25(OH)2 vitamin D3-stimulated osteoclast formation in spleen-osteoblast cocultures is mediated in part by enhanced IL-1 alpha and receptor activator of NF-kappa B ligand production in osteoblasts.
    Lee SK, Kalinowski J, Jastrzebski S, Lorenzo JA.
    J Immunol; 2002 Sep 01; 169(5):2374-80. PubMed ID: 12193704
    [Abstract] [Full Text] [Related]

  • 7. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ, Wronski TJ, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, Halloran BP.
    J Bone Miner Res; 2005 Sep 01; 20(9):1659-68. PubMed ID: 16059637
    [Abstract] [Full Text] [Related]

  • 8. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
    Udagawa N, Takahashi N, Yasuda H, Mizuno A, Itoh K, Ueno Y, Shinki T, Gillespie MT, Martin TJ, Higashio K, Suda T.
    Endocrinology; 2000 Sep 01; 141(9):3478-84. PubMed ID: 10965921
    [Abstract] [Full Text] [Related]

  • 9. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex.
    Youn HS, Lee JY, Fitzgerald KA, Young HA, Akira S, Hwang DH.
    J Immunol; 2005 Sep 01; 175(5):3339-46. PubMed ID: 16116226
    [Abstract] [Full Text] [Related]

  • 10. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling.
    Hoebe K, Du X, Georgel P, Janssen E, Tabeta K, Kim SO, Goode J, Lin P, Mann N, Mudd S, Crozat K, Sovath S, Han J, Beutler B.
    Nature; 2003 Aug 14; 424(6950):743-8. PubMed ID: 12872135
    [Abstract] [Full Text] [Related]

  • 11. Antagonism between MyD88- and TRIF-dependent signals in B7RP-1 up-regulation.
    Zhou Z, Hoebe K, Du X, Jiang Z, Shamel L, Beutler B.
    Eur J Immunol; 2005 Jun 14; 35(6):1918-27. PubMed ID: 15884053
    [Abstract] [Full Text] [Related]

  • 12. Signaling of apoptosis through TLRs critically involves toll/IL-1 receptor domain-containing adapter inducing IFN-beta, but not MyD88, in bacteria-infected murine macrophages.
    Ruckdeschel K, Pfaffinger G, Haase R, Sing A, Weighardt H, Häcker G, Holzmann B, Heesemann J.
    J Immunol; 2004 Sep 01; 173(5):3320-8. PubMed ID: 15322195
    [Abstract] [Full Text] [Related]

  • 13. Regulation of lipopolysaccharide-inducible genes by MyD88 and Toll/IL-1 domain containing adaptor inducing IFN-beta.
    Hirotani T, Yamamoto M, Kumagai Y, Uematsu S, Kawase I, Takeuchi O, Akira S.
    Biochem Biophys Res Commun; 2005 Mar 11; 328(2):383-92. PubMed ID: 15694359
    [Abstract] [Full Text] [Related]

  • 14. Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts.
    Takami M, Takahashi N, Udagawa N, Miyaura C, Suda K, Woo JT, Martin TJ, Nagai K, Suda T.
    Endocrinology; 2000 Dec 11; 141(12):4711-9. PubMed ID: 11108286
    [Abstract] [Full Text] [Related]

  • 15. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages.
    Schilling D, Thomas K, Nixdorff K, Vogel SN, Fenton MJ.
    J Immunol; 2002 Nov 15; 169(10):5874-80. PubMed ID: 12421970
    [Abstract] [Full Text] [Related]

  • 16. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
    Yip KH, Zheng MH, Feng HT, Steer JH, Joyce DA, Xu J.
    J Bone Miner Res; 2004 Nov 15; 19(11):1905-16. PubMed ID: 15476591
    [Abstract] [Full Text] [Related]

  • 17. Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappaB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture.
    Komine M, Kukita A, Kukita T, Ogata Y, Hotokebuchi T, Kohashi O.
    Bone; 2001 May 15; 28(5):474-83. PubMed ID: 11344046
    [Abstract] [Full Text] [Related]

  • 18. Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors.
    Kikuchi T, Matsuguchi T, Tsuboi N, Mitani A, Tanaka S, Matsuoka M, Yamamoto G, Hishikawa T, Noguchi T, Yoshikai Y.
    J Immunol; 2001 Mar 01; 166(5):3574-9. PubMed ID: 11207318
    [Abstract] [Full Text] [Related]

  • 19. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
    Chikazu D, Katagiri M, Ogasawara T, Ogata N, Shimoaka T, Takato T, Nakamura K, Kawaguchi H.
    J Bone Miner Res; 2001 Nov 01; 16(11):2074-81. PubMed ID: 11697804
    [Abstract] [Full Text] [Related]

  • 20. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ.
    J Bone Miner Res; 2000 Aug 01; 15(8):1459-66. PubMed ID: 10934644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.